Daniel Devine & Co’s AbbVie ABBV Stock Holding History

Daniel Devine & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$2.49M	Sell	26,880 -3,500	-12%	-$342K	1.99%	9
2018 Q1	$2.88M	Sell	30,380 -200	-0.7%	-$22K	2.34%	8
2017 Q4	$2.96M	Hold	30,580	–	–	2.14%	9
2017 Q3	$2.72M	Hold	30,580	–	–	2.08%	9
2017 Q2	$2.22M	Sell	30,580 -3,800	-11%	-$255K	1.81%	10
2017 Q1	$2.24M	Sell	34,380 -11,750	-25%	-$739K	1.84%	12
2016 Q4	$2.89M	Hold	46,130	–	–	2.06%	9
2016 Q3	$2.91M	Sell	46,130 -50	-0.1%	-$3.24K	1.95%	13
2016 Q2	$2.86M	Hold	46,180	–	–	1.95%	12
2016 Q1	$2.64M	Buy	46,180 +14,200	+44%	+$791K	1.72%	13
2015 Q4	$1.89M	Hold	31,980	–	–	1.25%	20
2015 Q3	$1.74M	Buy	31,980 +2,175	+7%	+$142K	1.23%	21
2015 Q2	$2M	Hold	29,805	–	–	1.38%	18
2015 Q1	$1.75M	Buy	29,805 +9,900	+50%	+$598K	1.17%	25
2014 Q4	$1.3M	Buy	+19,905	New	+$1.25M	0.93%	30

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Daniel Devine & Co's ABBV Position: Q2 2018 in Review

Daniel Devine & Co reduced its AbbVie (ABBV) stake by 12% in Q2 2018, selling an estimated $342K and leaving 26,880 shares worth $2.49M. The position accounts for 1.99% of the portfolio, ranked #9.

Daniel Devine & Co first reported a position in ABBV in Q4 2014 and has held it in 15 quarters since. The position peaked at $2.96M in Q4 2017. 1,997 funds tracked by Wall St. Rank hold ABBV as of Q2 2018.

Daniel Devine & Co held 26,880 shares of AbbVie worth $2.49M as of Q2 2018.
Daniel Devine & Co sold 3,500 AbbVie shares in Q2 2018, an estimated $342K.
AbbVie made up 1.99% of Daniel Devine & Co's portfolio in Q2 2018, its #9 holding.
Daniel Devine & Co first reported a position in AbbVie in Q4 2014 and has held it in 15 quarters since.
Daniel Devine & Co's AbbVie position peaked at $2.96M in Q4 2017.
1,997 funds tracked by Wall St. Rank held AbbVie as of Q2 2018.

Based on Daniel Devine & Co's 13F filing for Q2 2018, filed 18 Jul 2018.